혁신 신약 개발로 인류의 삶의 질 개선에 기여하는
글로벌 바이오 기업 CG인바이츠
연구개발 논문
-
공지사항
(2022) CG-745-2-08: GASTROINTESTINAL CANCER - GASTROESOPHAGEAL, PANCRE..
CG-745-2-08: A Phase 1b/2, Dose-escalation, Randomized, Multicenter Study of Maintenance Ivaltinostat plus Capecitabin..
2022.06.07 -
공지사항
(2020) Kim, Y.D. et al. HDAC Inhibitor, CG-745, enhances the anti-canc..
2021.06.21 -
공지사항
(2020) Suh, S.H. et al. CG200745, a novel HDAC inhibitor, attenuates k..
2021.06.21 -
공지사항
(2019) Yoon, G.E. et al. Histone deacetylase inhibitor CG200745 amelio..
2021.06.21 -
공지사항
(2020) Kim, Y.I. et al. Local Stabilization of Hypoxia-Inducible Facto..
2021.06.21 -
공지사항
(2019) Bae, E.H. et al. Renoprotective effect of the histone deacetyla..
2021.06.21 -
공지사항
(2019) Kim, Y.S. et al. The anti-fibrotic effects of CG-745, an HDAC i..
2021.06.21 -
공지사항
(2018) Choi, H.S. et al. Histone deacetylase inhibitor, CG200745 atten..
2021.06.21 -
공지사항
(2017) Lee, M.C. A Randomized, Multicenter, Phase III Trial to Evaluat..
2021.06.21